O'Shaughnessy Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1
Closed 2578
2021
Q3
$0 Hold
1
﹤0.01% 2877
2021
Q2
$0 Hold
1
﹤0.01% 2710
2021
Q1
$0 Hold
1
﹤0.01% 2481
2020
Q4
$0 Hold
1
﹤0.01% 2253
2020
Q3
$0 Hold
1
﹤0.01% 2032
2020
Q2
$0 Hold
1
﹤0.01% 1931
2020
Q1
$0 Hold
1
﹤0.01% 1878
2019
Q4
$0 Buy
+1
New +$3 ﹤0.01% 1924
2018
Q2
Sell
-24,942
Closed -$137K 1012
2018
Q1
$137K Sell
24,942
-97,392
-80% -$686K ﹤0.01% 580
2017
Q4
$997K Sell
122,334
-9,159
-7% -$87.5K 0.02% 276
2017
Q3
$1.38M Buy
131,493
+45,091
+52% +$500K 0.03% 247
2017
Q2
$954K Sell
86,402
-33,279
-28% -$310K 0.02% 285
2017
Q1
$1M Sell
119,681
-10,478
-8% -$73.8K 0.02% 286
2016
Q4
$903K Sell
130,159
-16,076
-11% -$103K 0.02% 285
2016
Q3
$744K Buy
146,235
+47,614
+48% +$284K 0.02% 297
2016
Q2
$589K Buy
+98,621
New +$547K 0.02% 317

Other funds holding ENZ

O'Shaughnessy Asset Management's ENZ Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 1 share.

O'Shaughnessy Asset Management first reported a position in ENZ in Q2 2016 and held it in 16 quarters. The position peaked at $1.38M in Q3 2017. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1 Enzo Biochem, Inc. share in Q4 2021.
  • O'Shaughnessy Asset Management first reported a position in Enzo Biochem, Inc. in Q2 2016 and held it in 16 quarters.
  • O'Shaughnessy Asset Management's Enzo Biochem, Inc. position peaked at $1.38M in Q3 2017.
  • 59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.